The Importance of Colorectal Cancer Screening: How Early Detection Saves Lives
Colorectal cancer ranks as the second leading cause of cancer-related deaths in the United States. Referred to as a “silent killer” due to its lack of…
Update your location to show providers, locations, and services closest to you.
Inflammatory bowel disease (IBD) is a term that refers to two inflammatory conditions, including Crohn’s disease and ulcerative colitis. Approximately 1.6 million Americans suffer from IBD, most likely to be seen in patients between the ages of 15 and 30.
At UF Health, we take even the most difficult to treat, complex cases for the full-range of IBD, including:
Our multidisciplinary team is committed to improving the lives of individuals suffering from inflammatory bowel diseases by providing the highest level of personalized patient care, advancing research and discovering innovative treatment options through our numerous clinical trials. Together, we bring together decades of digestive disease expertise from a wide range of clinical specialties.
We are dedicated to discovering new, more effective ways to diagnose and treat the full spectrum of digestive disease through leading-edge research and clinical trials. Patients benefit from the most advanced treatments available and the expertise of our clinician scientists.
To learn more about clinical trials currently being offered or to request a consult, please call (352) 265-8971
Our care team is comprised of board-certified gastroenterologists, colorectal surgeons, rheumatologists, a pharmacist and dedicated triage nurses, along with our endoscopists, dietitians, pathologists and clinical psychologists with expertise in dealing with inflammatory disorders.
Want to know more? Check out our Patient Education section for more information.
Colorectal cancer ranks as the second leading cause of cancer-related deaths in the United States. Referred to as a “silent killer” due to its lack of…
June 23, 2023
JUPITER, Fla. — Targeting a master-regulator of inflammation with a monoclonal antibody potentially improves two unrelated conditions with limited treatment…
The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology
It’s enough of a problem living with the inconveniences of inflammatory bowel disease. Forms of this condition, like Crohn’s disease and ulcerative colitis, both cause emergency trips to the...
It’s enough of a problem living with the inconveniences of inflammatory bowel disease. Forms of this condition, like Crohn’s disease and ulcerative colitis, both cause emergency trips to the...